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To determine whether nicotine-containing vaping products submitted to the 
Medicines and Healthcare products Regulatory Agency (MHRA) under the Tobacco 
and Related Products Regulations 2016 contain tetrahydrocannabinol or vitamin E 
acetate.  
Methods  
Analysis of data on ingredients for all products submitted for notification for the UK 
market by October 2017 to assess whether any were reported to contain vitamin E 
acetate or THC. The analysis was not pre-registered and the results should therefore 
be considered exploratory. 
Results 
Vitamin E acetate and THC were not listed as an ingredient or emission in any of the 
41,809 products that were submitted for notification. 
Conclusions  
In the UK, vapers and those considering switching from tobacco to vaping can be 
reassured that licit products available on the UK market do not contain 







E-cigarettes, while the the subject of significant global controversy, have been 
promoted in the UK as a reduced-harm substitute for combustible tobacco use.(1, 2) 
A recent outbreak of serious respiratory illness among vapers in North America,  
attributed at least in part to the use of illicit e-liquids containing tetrahydrocannabinol 
(THC, which is illegal for recreational use in the UK) and vitamin E acetate, has led 
to concern that similar cases may also arise among vapers in the UK.(3) Although 
the exact cause of this outbreak is still not known – for example, THC per se may not 
have negative respiratory effects, but may be combined in e-liquids with ingredients 
which are harmful when inhaled as vapour - it is important to reassure UK vapers 
that licit products on the UK market do not contain the ingredients that are implicated 
in these cases. We have therefore searched UK data on nicotine-containing vaping 
products submitted to the Medicines and Healthcare products Regulatory Agency 
(MHRA) under the Tobacco and Related Products Regulations 2016 to determine 
whether there are any that contain these substances.  
 
Methods 
The European Union Tobacco Products Directive requires producers of nicotine-
containing vaping products to disclose information by brand and variant name on 
ingredients, emissions, toxicology, nicotine dose and uptake, and sales volumes to 
the MHRA (4). We have analysed data on ingredients for all products submitted for 
notification for the UK market by October 2017 to assess whether any were reported 
to contain vitamin E acetate or THC. Search terms (See online supplementary 
material) included vitamin E acetate, vitamin E acetate synonyms listed on PubChem 
(5), and all potential Chemical Abstract Service (CAS) numbers for Vitamin E acetate 
 
(58-95-7, 7695-91-2, 52225-20-4); and THC, its synonyms listed on PubChem (6) 
and all potential CAS numbers for THC (1972-08-3, 6465-30-1). 
 
Results  
A total number of 41 809 products, comprising cartridges and refill containers, were 
assessed for the presence of Vitamin E Acetate and THC. Vitamin E acetate and 
THC were not listed as an ingredient or emission in any of the provided products. 
854 (2.04%) of notified products had listed flavours but not specific ingredients; their 
composition is therefore unknown.  
 
Conclusions 
Vitamin E acetate has been implicated alongside THC in the recent outbreak of 
severe disease in the USA (7) and the fact that the outbreak has, to date, been 
limited to North America suggests that a specific exposure or exposures arising from 
e-liquids available in that region are responsible. Two prime candidate constituents 
are THC and vitamin E acetate. In the UK, vapers and those considering switching 
from tobacco to vaping can therefore be reassured that licit products available on the 
UK market do not contain these ingredients. THC is illegal in the UK and it is 
therefore not surprising that this ingredient is not listed as being present in any licit 
products; our data do not include illicit products and it is possible that illicit products 
similar to those available in the US are available in the UK.(8) Vapers should use 
exclusively licit products which are subject to MHRA regulatory procedures. 
 
Our data represent a snapshot of products notifed at a single point of time and the 
dataset does not include products that have been notifed since the reporting period. 
 
The reporting system also relies on the integrity of the reports submitted to member 
states via the European submission portal. On-going improvements to the 
functionality of the EU system since 2017 have enabled member states to carry out 
more rigorous assessment of the data provided by producers. Since late 2017 the 
MHRA has implemented a process to check all products to ensure that they do not 
contain prohibited substances, including THC and vitamin E acetate.  No notified 
product on the UK published list includes these prohibited substances [personal 
communication, MHRA]. Our data show that even prior to this more rigorous 
process, none of the notified products contained THC or Vitamin E acetate and thus 
should reassure smokers that this particular risk does not apply in the UK. Vapers 
who are unsure of the provenance of e-liquid products are encouraged to check 
that the product has been notified and published by the MHRA.(9) 
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